Lowering the recommended age for baseline prostate-specific antigen (PSA) would reduce prostate cancer deaths by about 30% in Black men without significantly increasing the rate of overdiagnosis, according to new screening guidelines from the Prostate Cancer Foundation. Specifically, baseline PSA testing in Black men should begin at age 40-45, sooner than current guidelines recommend, and...